This 30-minute session expands on the STS Roadmap to Mobile Lung Cancer Screenings and examines the intricacies of mobile cancer screening units and how they operate. The event is open to all interested in creating or expanding a mobile cancer screening initiative at their institution.
Moderator
Elliot L. Servais, MD Lahey Hospital & Medical Center Burlington, MA
This webinar will review significant lung infections such as costicercosis, tuberculosis and hidatidosis. Our expert panel with US and LATAM speakers will go over controversial topics on these 3 diseases, including state-of-the-art management and different options in surgical approach.
This webinar will explore the evolving landscape of neoadjuvant and adjuvant treatment for lung cancer. Oncologists and surgeon experts will highlight the latest data, including immunotherapy and targeted mutation strategies from ASCO and WCLC, and examine how these advances impact surgical decision-making, techniques, and patient outcomes. A live discussion will address key controversies, including the role of radiation and adjuvant therapy choices.
Supported by AstraZeneca
Moderator
Joseph Shrager, MD Stanford University Palo Alto, CA
The premier annual event in cardiothoracic surgery, unveiling never-before-seen science, techniques, and technology, and creating a forum to build lasting connections with colleagues.
The STS Leadership Institute helps members in their first 15 years of practice to develop the skills necessary to lead teams in and out of the OR, strategize personal and professional goals, negotiate a career path, and influence change in the workplace.
Diversity in the physician workforce is a key component of delivering the best care to our increasingly heterogeneous patient population. The experience of Asians in cardiothoracic surgery is not well known. With a paucity of published evidence, the webinar panel will introduce the topic through the lived experience of Asians in the specialty. The discussion will explore:
Aortic regurgitation is an undertreated condition, often because patients are not referred in a timely fashion for intervention. During this STS webinar, attendees will hear from an expert panel on the evidence base for timing of intervention as well as evolving treatment options. Conventional surgical aortic valve repair can be considered alongside the Ross procedure and transcatheter interventions with dedicated devices. Webinar participants will be better informed on how to treat this patient population.
The management of stage IIIA non-small cell lung cancer (NSCLC) is evolving in the era of immune checkpoint inhibitor therapy. In the past, there has been a great deal of controversy regarding the optimal management of patients with N2 nodal metastasis at the time of diagnosis of NSCLC. There are some new questions to address when considering the results of the Checkmate 816 and the NADIM II clinical trials which demonstrated improved disease-free survival and overall survival with neoadjuvant combined chemotherapy and Nivolumab.
